Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase I contract was awarded to PROLX PHARMACEUTICALS CORPORATION from the U.S. Department of Health & Human Services. | SBIR | 2R44CA078003-02 | Phase I | 0 | ||||||||
A SBIR Phase II contract was awarded to PROLX PHARMACEUTICALS CORPORATION for $1,626,720.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44CA109864-02 | Phase II | 1,626,720 | ||||||||
A SBIR Phase I contract was awarded to PROLX PHARMACEUTICALS CORPORATION for $191,208.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA109864-01A1 | Phase I | 191,208 | ||||||||
A SBIR Phase I contract was awarded to PROLX PHARMACEUTICALS CORPORATION for $405,841.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA107644-01 | Phase I | 405,841 | ||||||||
A SBIR Phase I contract was awarded to PROLX PHARMACEUTICALS CORPORATION for $193,617.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA112691-01 | Phase I | 193,617 | ||||||||
A SBIR Phase II contract was awarded to PROLX PHARMACEUTICALS CORPORATION for $2,578,164.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44CA078003-02 | Phase II | 2,578,164 | ||||||||
A SBIR Phase II contract was awarded to PROLX PHARMACEUTICALS CORPORATION for $2,966,230.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44CA075923-06A2 | Phase II | 2,966,230 | ||||||||
A STTR Phase I contract was awarded to PROLX PHARMACEUTICALS CORPORATION for $130,000.0 USD from the U.S. Department of Health & Human Services. | STTR | Phase I | 130,000 | |||||||||
A SBIR Phase I contract was awarded to PROLX PHARMACEUTICALS CORPORATION for $251,384.0 USD from the U.S. Department of Health & Human Services. | SBIR | Phase I | 251,384 | |||||||||
A SBIR Phase I contract was awarded to PROLX PHARMACEUTICALS CORPORATION for $188,860.0 USD from the U.S. Department of Health & Human Services. | SBIR | Phase I | 188,860 | |||||||||
A SBIR Phase I contract was awarded to PROLX PHARMACEUTICALS CORPORATION for $259,028.0 USD from the U.S. Department of Health & Human Services. | SBIR | Phase I | 259,028 |